Kevzara 200 MG/1.14 ML pen INJ 1.14ML

Ended Awarded Last action

Contract number
SPE2DR26F4F2D
Awardee
Awarding agency
Obligated
$19,481

Award facts

Contract value 100% obligated
$19,481.06 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a $19,481.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Kevzara 200 mg/1.14 ml pen injections. This is a non-set-aside competitive award with performance at the awardee's facility in Conshohocken, Pennsylvania, and an ultimate completion date of January 20, 2026. Kevzara is a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions, and this delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical.

AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., holds a significant $999,999,999 IDC with the DLA Troop Support Medical extending through December 2026, which serves as the vehicle for this pharmaceutical delivery order. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical devices to support military healthcare programs and other government medical institutions. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill competitive procurement requirements across multiple therapeutic domains and product categories for the Department of Defense and affiliated healthcare systems.

Quick answers

Who was awarded contract SPE2DR26F4F2D?

SPE2DR26F4F2D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.

How much is contract SPE2DR26F4F2D worth?

The government has obligated $19,481 on SPE2DR26F4F2D.

Is contract SPE2DR26F4F2D an order under another contract?

Yes. SPE2DR26F4F2D is a delivery order under SPE2DR25D3012, an indefinite delivery contract.

Was contract SPE2DR26F4F2D competed?

The extent of competition for SPE2DR26F4F2D was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award